Search

everythinglearnresearchcommunity

for

Search:↓

Eating 500 fewer calories a day and making lifestyle changes can improve PCOS symptoms and reduce diabetes risk; more research is needed on its causes and treatments.

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

Hair growth is influenced by interactions between skin layers, growth factors, and hormones, but the exact mechanisms are not fully understood.

The conclusion is that understanding how feathers and hairs pattern can help in developing hair regeneration treatments.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

The document concludes that there is no agreed-upon best method for measuring drug delivery within hair follicles and more research is needed to validate current techniques.

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

Many young Australian women think they have PCOS, but only a few are diagnosed correctly, causing unnecessary worry.

Minoxidil and finasteride can help with hair loss, but more research is needed to improve treatments for certain types of hair loss.

The conclusion is that skin and hair patterns are formed by a mix of cell activities, molecular signals, and environmental factors.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Different diagnostic criteria greatly affect PCOS diagnosis rates in teenagers.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Hormones and genes affect hair growth and male baldness.

Patients with schizophrenia have a high rate of skin diseases, with fungal infections and dermatitis being most common, and those on clozapine have a lower risk of fungal infections.

Obstetrician/gynecologists can diagnose and manage female hair loss with careful history taking and examination.

Combining mood stabilizers with antipsychotics is more effective for treating children with bipolar disorder than using mood stabilizers alone.

Hirsutism is common body hair growth due to genetics and hormones, and while not a disease, it can be distressing; virilisation includes hirsutism with other male traits and needs medical attention.

Transfollicular drug delivery is promising but needs more research to improve and understand it better.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.